Company intelligence / Profile preview

Cemit

Ownership: Private
Development stage: Other

Overview

Cemvita has achieved significant milestones in bioprocess productivity, including efficient microbial conversion of crude glycerin to sustainable oil at its Houston pilot plant. The company is advancing toward commercial deployment of its technologies, with ongoing partnerships and expansion into new markets such as Brazil. Its solutions are designed to decarbonize heavy industries by producing sustainable oils, chemicals, fuels, and feedstocks from carbon emissions and industrial waste using engineered microbes[1][2][3].

Therapeutic areas: Other
Modalities: Microbial biomanufacturingSynthetic biology platforms (using engineered microbes)
Industry: Non-Drug Biotech

Partnerships

Oxy Low Carbon Ventures/Oxy[1][3]United Airlines[1]REMA (Brazil)[3]Be8 Bioenergia S.A. ("Be8", Brazil)[3]

Beyond the preview

Go deeper on Cemit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cemit.

Explore the full profile